Hypertriglyceridemia  >>  niacin extended-release formulation  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
niacin extended-release formulation / Generic mfg.
NCT01200160: Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Completed
N/A
128
RoW
Niacin, Niaspan
Abbott, QUASY
Cardiovascular Diseases
05/12
05/12

Download Options